{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:30:34Z","timestamp":1788442234490,"version":"build-2803163510"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-026-06269-5","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T07:57:58Z","timestamp":1770883078000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Dynamic 18\u00a0F-PSMA-1007 PET-CT kinetics as a prognostic marker in newly diagnosed prostate cancer: a prospective pilot study"],"prefix":"10.1007","volume":"44","author":[{"given":"Tarun Kumar","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patel","family":"Meet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur","family":"Punia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoti Lal","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subham","family":"Dadhich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaitanya","family":"Kalani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaushiki","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maneesh Kumar","family":"Vijay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anushree","family":"loyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemant","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"6269_CR1","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/ijc.33588","volume":"149","author":"J Ferlay","year":"2021","unstructured":"Ferlay J, Colombet M, Soerjomataram I et al (2021) Cancer statistics for the year 2020: an overview. Int J Cancer 149:778\u2013789","journal-title":"Int J Cancer"},{"key":"6269_CR2","first-page":"479","volume":"17","author":"JL Mohler","year":"2019","unstructured":"Mohler JL, Antonarakis ES, Armstrong AJ, D\u2019Amico AV, Davis BJ, Dorff T et al (2019) Prostate Cancer, version 2.2019, NCCN clinical practice guidelines in oncology. J Natl ComprCancNetw 17:479\u2013505","journal-title":"J Natl ComprCancNetw"},{"key":"6269_CR3","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","volume":"395","author":"MS Hofman","year":"2020","unstructured":"Hofman MS, Lawrentschuk N, Francis RJ, Tang C, Vela I, Thomas P et al (2020) Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet 395:1208\u20131216","journal-title":"Lancet"},{"key":"6269_CR4","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.eururo.2021.08.002","volume":"80","author":"L Emmett","year":"2021","unstructured":"Emmett L, Buteau J, Papa N, Moon D, Thompson J, Roberts MJ, Rasiah K et al (2021) The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance imaging triage in the diagnosis of prostate cancer (PRIMARY): A prospective multicentre study. Eur Urol 80:682\u2013689","journal-title":"Eur Urol"},{"key":"6269_CR5","doi-asserted-by":"publisher","first-page":"286","DOI":"10.2214\/AJR.18.19957","volume":"211","author":"TA Hope","year":"2018","unstructured":"Hope TA, Afshar-Oromieh A, Eiber M, Emmett L, Fendler WP, Lawhn-Heath C et al (2018) Imaging prostate cancer with prostate-Specific membrane antigen PET\/CT and PET\/MRI: current and future applications. AJR Am J Roentgenol 211:286\u2013294","journal-title":"AJR Am J Roentgenol"},{"key":"6269_CR6","doi-asserted-by":"crossref","unstructured":"Meher N, VanBrocklin HF, Wilson DM, Flavell RR (2023) PSMA-Targeted nanotheranostics for imaging and radiotherapy of prostate cancer. Pharmaceuticals (Basel)","DOI":"10.3390\/ph16020315"},{"key":"6269_CR7","doi-asserted-by":"crossref","unstructured":"Jani AB, Ravizzini GC, Gartrell BA, Siegel BA, Twardowski P, Saltzstein D et al (2023) Diagnostic performance and safety of (18) F-rhPSMA-7.3 positron emission tomography in men with suspected prostate cancer recurrence: results from a phase 3, Prospective, multicenter study (SPOTLIGHT). J Urol. :101097ju0000000000003493","DOI":"10.1097\/JU.0000000000003598"},{"key":"6269_CR8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2967\/jnumed.121.263262","volume":"63","author":"H Jadvar","year":"2022","unstructured":"Jadvar H, Calais J, Fanti S, Feng F, Greene KL, Gulley JL et al (2022) Appropriate use criteria for Prostate-Specific membrane antigen PET imaging. J Nucl Med 63:59\u201368","journal-title":"J Nucl Med"},{"key":"6269_CR9","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1148\/radiol.2021202771","volume":"299","author":"C Lawhn-Heath","year":"2021","unstructured":"Lawhn-Heath C, Salavati A, Behr SC, Rowe SP, Calais J, Fendler WP et al (2021) Prostate-specific membrane antigen PET in prostate cancer. Radiology 299:248\u2013246","journal-title":"Radiology"},{"key":"6269_CR10","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1007\/s00259-022-06089-w","volume":"50","author":"WP Fendler","year":"2023","unstructured":"Fendler WP, Eiber M, Beheshti M, Bomanji J, Calais J, Ceci F et al (2023) PSMA PET\/CT: joint EANM procedure guideline\/SNMMI procedure standard for prostate cancer imaging 2.0. Eur J Nucl Med Mol Imaging 50:1466\u20131486","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6269_CR11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2967\/jnumed.117.191874","volume":"59","author":"NM Donin","year":"2018","unstructured":"Donin NM, Reiter RE (2018) Why targeting PSMA is a game changer in the management of prostate cancer. J Nucl Med 59:177\u2013182","journal-title":"J Nucl Med"},{"key":"6269_CR12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/CCO.0000000000000439","volume":"30","author":"K Bouchelouche","year":"2018","unstructured":"Bouchelouche K, Choyke PL (2018) Advances in prostate-specific membrane antigen PET of prostate cancer. Curr Opin Oncol 30:189\u2013196","journal-title":"Curr Opin Oncol"},{"key":"6269_CR13","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/JU.0000000000001698","volume":"206","author":"KJ Pienta","year":"2021","unstructured":"Pienta KJ, Gorin MA, Rowe SP, Carroll PR, Pouliot F, Probst S et al (2021) A phase 2\/3 prospective multicenter study of the diagnostic accuracy of prostate specific membrane antigen PET\/CT with (18)F-DCFPyL in prostate cancer patients (OSPREY). J Urol 206:52\u201361","journal-title":"J Urol"},{"key":"6269_CR14","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00259-020-04782-2","volume":"48","author":"M Wondergem","year":"2021","unstructured":"Wondergem M, van der Zant FM, Broos WAM, Roeleveld TA, Donker R, Ten Oever D et al (2021) (18)F-DCFPyL PET\/CT for primary staging in 160 high-risk prostate cancer patients; metastasis detection rate, influence on clinical management and preliminary results of treatment efficacy. Eur J Nucl Med Mol Imaging 48:521\u2013531","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06269-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-026-06269-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06269-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T07:58:01Z","timestamp":1770883081000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-026-06269-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6269"],"URL":"https:\/\/doi.org\/10.1007\/s00345-026-06269-5","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"29 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written informed consent was taken from the patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"162"}}